Welcome to CapLaw

CapLaw is a digital newsletter with international reach established and led by the General Editors. We provide up-to-date information on legal and regulatory developments regarding the capital markets, publish concise articles on developments in the Swiss and international financial markets, and announce recent deals and forthcoming events. CapLaw is addressed to all Swiss and international lawyers, in-house counsel, financial institutions and corporates, as well as those who are interested in the Swiss capital markets.

The General Editors
René Bösch, Homburger AG
Matthias Courvoisier, Baker McKenzie Switzerland AG
Benjamin Leisinger, Homburger AG
Ralph Malacrida, Bär & Karrer AG
Nina Reiser, University of St.Gallen
Thomas Reutter, Advestra AG
Patrick Schleiffer, Lenz & Staehelin
Philippe A. Weber, Niederer Kraft & Frey AG
Thomas Werlen, Quinn Emanuel Urquhart & Sullivan, LLP

CapLaw Themes
CapLaw PDF Archive
  • FINMA’s New Climate Risk Disclosure Requirements as a Step Towards a More Comprehensive Mandatory ESG Disclosure Regime in Switzerland

    Recent years have seen regulatory institutions around the world introduce mandatory corporate disclosure regimes related to climate and environmental, social and governance (“ESG“) matters, largely as a response to the increasing materialization of ESG risks, in particular global heating and climate-driven natural catastrophes, as well as the growing awareness of the importance of full and…

    By

    Deirdre Ní Annracháin

    Reference:
    Read more: FINMA’s New Climate Risk Disclosure Requirements as a Step Towards a More Comprehensive Mandatory ESG Disclosure Regime in Switzerland
  • IPO of Switzerland’s First SPAC

    On 6 December 2021, VT5 Acquisition Company AG (VT5), a special purpose acquisition company (SPAC), announced the launch of its initial public offering and the listing of its Class A Shares and redeemable warrants on SIX Swiss Exchange, which is scheduled for 15 December 2021. VT5 plans the acquisition of one or more operating companies…

    By

    CapLaw

    Reference:
    Read more: IPO of Switzerland’s First SPAC
  • Novartis sells stake in Roche

    On 3 November 2021, Novartis agreed to sell 53.3 million Roche bearer shares in a bilateral transaction to Roche for a consideration of CHF 19 billion. Novartis had acquired the stake between 2001 and 2003. The transaction is subject to the approval by the shareholders of Roche.

    By

    CapLaw

    Reference:
    Read more: Novartis sells stake in Roche
  • IPO of SKAN Group

    On 27 October 2021, SKAN Group AG, a global market leader in high-quality isolator systems for aseptic production processes in the (bio)pharmaceutical industry, announced the pricing of its IPO, consisting of 1,731,494 newly issued shares and 2,768,506 existing shares and an over-allotment option of up to 500,000 shares, at CHF 54 per share, implying a…

    By

    CapLaw

    Reference:
    Read more: IPO of SKAN Group
  • Spin-off and IPO of medmix

    On 1 October 2021, the shares of medmix AG were listed at SIX Swiss Exchange following the spin-off of medmix from Sulzer AG. Concurrently, medmix conducted a capital increase raising gross proceeds of CHF 315 million.

    By

    CapLaw

    Reference:
    Read more: Spin-off and IPO of medmix
  • UBS Group Notes Issuances

    Between 3 and 9 November 2021, UBS Group AG successfully completed the issuance under its Senior Debt Programme of EUR 1.25 billion in aggregate principal amount of 0.250 per cent. Fixed Rate/Fixed Rate Callable Senior Notes due November 2026, and EUR 1.25 billion in aggregate principal amount of 0.875 per cent. Fixed Rate Senior Notes…

    By

    CapLaw

    Reference:
    Read more: UBS Group Notes Issuances
  • Santhera Pharmaceuticals equity financing

    On September 22, 2021, Santhera Pharmaceuticals Holding AG announced an equity financing of CHF 20 million via a private placement of shares, a placement of private convertible bonds of CHF 15 million and upsizing of an existing financing arrangement of up to CHF 10 million. In addition, Santhera agreed to issue warrants to participating investors.

    By

    CapLaw

    Reference:
    Read more: Santhera Pharmaceuticals equity financing
  • IPO of On Holding on NYSE

    On 15 September 2021, On Holding AG, an athletic shoe and performance sportswear company, successfully completed its initial public offering on the New York Stock Exchange (NYSE). The offering consisted of 31,100,000 Class A ordinary shares, of which 25,442,391 were offered by On Holding AG and 5,657,609 were offered by the selling shareholders, and an…

    By

    CapLaw

    Reference:
    Read more: IPO of On Holding on NYSE
  • Swiss Life Green Bonds Issuance

    On 15 September 2021, Swiss Life issued EUR 600 million 0.500 per cent guaranteed green bonds due 2031. The bonds have been issued by Swiss Life Finance I AG and are unconditionally and irrevocably guaranteed by Swiss Life Holding AG. Swiss Life intends to apply an amount equal to the net proceeds of the bonds…

    By

    CapLaw

    Reference:
    Read more: Swiss Life Green Bonds Issuance
  • IPO of Sportradar on Nasdaq

    On 14 September 2021, Sportradar Group AG successfully commenced trading on the Nasdaq Global Select Market with a total market capitalization of approximately USD 8 billion. Sportradar is a leading global provider of sports betting and sports entertainment products and services, and the number one provider of business-to-business solutions to the global sports betting industry…

    By

    CapLaw

    Reference:
    Read more: IPO of Sportradar on Nasdaq